Compounds > naltrexone

naltrexone and Eczema, Atopic

naltrexone has been researched along with Eczema, Atopic in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (7.14)	18.7374
1990's	2 (14.29)	18.2507
2000's	6 (42.86)	29.6817
2010's	3 (21.43)	24.3611
2020's	2 (14.29)	2.80

Authors

Authors	Studies
Garland, T; Grindlay, DJC; Harman, KE; Olabi, B; Rogers, NK; Worboys, S	1
Brown, A; Grindlay, DJC; Harman, KE; Rogers, NK; Tasker, F	1
Ekelem, C; Juhasz, M; Khera, P; Mesinkovska, NA	1
Jaros, J; Lio, P	1
Fujii, M; Fukuno, S; Kohno, S; Mizutani, N; Nabe, T; Nakamura, T	1
Arbabi, M; Jaberian, M; Malekzad, F; Mohajer, M; Mohammadi, MR; Mohtasham, N; Nasiri, S; Roodsari, MR; Toosi, P	1
Andoh, T; Kuraishi, Y; Saito, A	1
Abramovits, W; Draelos, Z; Duffy, M; Fleischer, A; Green, E; Herzog, JL; Rothaul, A; Solomon, JA; Stough, D; Tansley, R; Werschler, W; Wolf, DI	1
Groene, D; Heyer, G; Martus, P	1
Kuraishi, Y; Maekawa, T; Nojima, H; Yamaguchi-Miyamoto, T	1
Bigliardi, PL; Bigliardi-Qi, M; Büchner, S; Jost, G; Rufli, T; Stammer, H	1
Diepgen, LT; Dotzer, M; Handwerker, OH; Heyer, G	1
Heyer, GR; Hornstein, OP	1
Monroe, EW	1

Reviews

4 review(s) available for naltrexone and Eczema, Atopic

Article	Year
What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 2: systemic therapies. Clinical and experimental dermatology, 2020, Volume: 45, Issue:8 Topics: Acetates; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Biological Therapy; Child; Complementary Therapies; Cyclopropanes; Cyclosporine; Cytochrome P-450 CYP1A2 Inducers; Dermatitis, Atopic; Eczema; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Naltrexone; Narcotic Antagonists; Omalizumab; Placebo Effect; Probiotics; Quinolines; Sulfides; Ustekinumab; Vitamin D	2020
What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies. Clinical and experimental dermatology, 2020, Volume: 45, Issue:8 Topics: Administration, Topical; Animals; Breast Feeding; Complementary Therapies; Dermatitis, Atopic; Eczema; Fatty Acids; Female; Humans; Hypothalamo-Hypophyseal System; Infant Formula; Infant, Newborn; Janus Kinase Inhibitors; Lacticaseibacillus rhamnosus; Milk; Naltrexone; Narcotic Antagonists; Pituitary-Adrenal System; Pregnancy; Probiotics; Skin Lightening Preparations; Steroids; Vitamin D; Whey Proteins	2020
Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review. JAMA dermatology, 2019, 02-01, Volume: 155, Issue:2 Topics: Administration, Oral; Administration, Topical; Chronic Disease; Dermatitis; Dermatitis, Atopic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Naltrexone; Narcotic Antagonists; Patient Satisfaction; Severity of Illness Index; Treatment Outcome; United States	2019
Recent studies of cutaneous nociception in atopic and non-atopic subjects. The Journal of dermatology, 1999, Volume: 26, Issue:2 Topics: Acetylcholine; Dermatitis, Atopic; Eczema; Histamine; Humans; Naltrexone; Nociceptors; Pruritus; Psoriasis; Skin; Urticaria	1999

Trials

6 trial(s) available for naltrexone and Eczema, Atopic

Article	Year
Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:8 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dermatitis, Atopic; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Pain Measurement; Pruritus; Treatment Outcome	2009
A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic derm Journal of drugs in dermatology : JDD, 2011, Volume: 10, Issue:8 Topics: Administration, Cutaneous; Administration, Topical; Adult; Antipruritics; Cross-Over Studies; Delayed-Action Preparations; Dermatitis, Atopic; Double-Blind Method; Drug Evaluation; Electronic Health Records; Emollients; Female; Humans; Intention to Treat Analysis; Male; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid; Treatment Outcome	2011
Efficacy of naltrexone on acetylcholine-induced alloknesis in atopic eczema. Experimental dermatology, 2002, Volume: 11, Issue:5 Topics: Acetylcholine; Adult; Blood Flow Velocity; Dermatitis, Atopic; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Nociceptors; Physical Stimulation; Pruritus; Skin	2002
Treatment of pruritus with topically applied opiate receptor antagonist. Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:6 Topics: Administration, Topical; Adult; Aged; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; Female; Humans; Male; Middle Aged; Naloxone; Naltrexone; Narcotic Antagonists; Pilot Projects; Prospective Payment System; Pruritus	2007
Opiate and H1 antagonist effects on histamine induced pruritus and alloknesis. Pain, 1997, Volume: 73, Issue:2 Topics: Adult; Cross-Over Studies; Dermatitis, Atopic; Double-Blind Method; Female; Histamine; Histamine H1 Antagonists; Humans; Iontophoresis; Male; Naltrexone; Narcotic Antagonists; Pruritus; Reference Values	1997
Efficacy and safety of nalmefene in patients with severe pruritus caused by chronic urticaria and atopic dermatitis. Journal of the American Academy of Dermatology, 1989, Volume: 21, Issue:1 Topics: Chronic Disease; Dermatitis, Atopic; Double-Blind Method; Humans; Naltrexone; Narcotic Antagonists; Placebos; Pruritus; Random Allocation; Urticaria	1989

Other Studies

4 other study(ies) available for naltrexone and Eczema, Atopic

Article	Year
Low Dose Naltrexone in Dermatology Journal of drugs in dermatology : JDD, 2019, Mar-01, Volume: 18, Issue:3 Topics: B-Lymphocytes; Clinical Trials as Topic; Dermatitis, Atopic; Dose-Response Relationship, Drug; Humans; Naltrexone; Narcotic Antagonists; Off-Label Use; Receptors, Opioid; Skin; T-Lymphocytes	2019
Ethanol aggravates itch-related scratching in hairless mice developing atopic dermatitis. European journal of pharmacology, 2009, Jun-02, Volume: 611, Issue:1-3 Topics: Administration, Oral; Animals; Capsaicin; Dermatitis, Atopic; Dibucaine; Ethanol; Female; Mice; Mice, Hairless; N-Methylaspartate; Naltrexone; Petrolatum; Pruritus; Skin Temperature	2009
Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin. The Journal of investigative dermatology, 2009, Volume: 129, Issue:12 Topics: Animals; Calcium; Dermatitis, Atopic; Ganglia, Spinal; Histamine; Histamine H1 Antagonists, Non-Sedating; Injections, Intradermal; Keratinocytes; Leukotriene B4; Male; Mast Cells; Mice; Mice, Inbred ICR; Naltrexone; Narcotic Antagonists; Neurons; Phosphorylcholine; Pruritus; Skin; Sphingomyelins; Sphingosine; Terfenadine	2009
Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis. Japanese journal of pharmacology, 2002, Volume: 90, Issue:2 Topics: Animals; Behavior, Animal; Chronic Disease; Dermatitis, Atopic; Female; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Naltrexone; Narcotic Antagonists; Pruritus; Skin	2002